This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: University of Utah Research Foundation, British Columbia Cancer Agency Branch, The University of North Carolina at Chapel Hill. Active years: 2025-2026.
Company Filing History:
2 out of 1,685 
1 out of 66 
1 out of 1,325 
Years Active: 2025-2026
Title: The Innovative Contributions of Philip S Bernard
Introduction
Philip S Bernard is a notable inventor based in Salt Lake City, UT. He has made significant contributions to the field of cancer research, particularly through his innovative patent related to cancer recurrence risk assessment. His work has the potential to impact the diagnosis and treatment of cancer, especially in patients with triple-negative breast cancer.
Latest Patents
Philip S Bernard holds a patent for a multigene assay designed to assess the risk of recurrence of cancer. This patent discloses biomarkers and methods for determining the risk of cancer recurrence in a subject. The methods include determining the level of expression of at least one MHCII gene, assessing the level of expression of at least one TIL gene, and calculating an Immune Activation Score for the subject. Additionally, the patent provides methods for diagnosing a subject with triple-negative breast cancer (TNBC) as having the TNBC Basal-like subtype, along with methods for treating cancer in a subject.
Career Highlights
Throughout his career, Philip S Bernard has worked with esteemed organizations such as the University of Utah Research Foundation and NanoString Technologies, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Philip has collaborated with notable coworkers, including Katherine (k-t) E Varley and Rachel L Stewart. Their combined expertise has contributed to advancements in cancer diagnostics and treatment methodologies.
Conclusion
Philip S Bernard's innovative work in cancer research exemplifies the impact of inventions on medical science. His contributions, particularly through his patent on cancer recurrence risk assessment, highlight the importance of ongoing research and collaboration in the fight against cancer.